Healthcare & Life Sciences
Orbital Therapeutics
Orbital Therapeutics is a Healthcare & Life Sciences startup, since acquired, 1 tracked investor.
acquired
acquired
Stage
1
Investors
About Orbital Therapeutics
Orbital Therapeutics is a startup. Orbital Therapeutics has been acquired. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Orbital Therapeutics was a preclinical circular RNA (circRNA) platform company developing next-generation therapies and vaccines targeting rare disease, oncology, and immunology. The company was acquired by Bristol Myers Squibb for $1.5B.
Explore Orbital Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.